The First Circuit affirmed a district court judgment that prevented pharmaceutical company Novo Nordisk Inc. from enforcing a confidentiality and noncompete agreement that it had entered into with a worker who was briefly laid off and rehired before leaving the company for BioMarin Pharmaceutical Inc.

Register to attend the latest in a series of USPTO webinars focused on intellectual property (IP) protection and enforcement in China.

The continued inequitable treatment of African-Americans and other communities of color is intolerable. We must reflect on how our actions demonstrate a commitment to diversity, equality, and inclusion through discussion, education, and implementation. And we must all find ways to come together, and no longer be torn apart.

The United States Patent and Trademark Office (USPTO) on June 3, 2020, launched the COVID-19 Response Resource Center to provide stakeholders and other interested parties with improved access to USPTO initiatives, programs, and other helpful intellectual property (IP)-related information regarding the COVID-19 outbreak.

The US Court of Appeals for the Federal Circuit on May 29, 2020, refused to alter a mixed ruling on the validity of Boston Scientific’s spinal stimulation patent.